A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity.

J Antibiot (Tokyo)

Exploratory Research Laboratories II, Daiichi-Sankyo Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630, Japan.

Published: September 2008

Bacterial phospho-N-acetylmuramyl-pentapeptide translocase (translocase I: EC 2.7.8.13) is a key enzyme in peptidoglycan biosynthesis, and a known target of antibiotics. Here we report a novel nucleoside inhibitor against translocase I, A-94964, isolated from the culture broth of the strain Streptomyces sp. SANK 60404. A-94964 inhibited bacterial translocase I with IC50 value of 1.1 microg/ml, and showed antimicrobial activities against Staphylococcus aureus and Enterococcus faecalis with MIC of 100 and 50 microg/ml, respectively. A-94964 did not show cytotoxicity against mammalian cell lines.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ja.2008.71DOI Listing

Publication Analysis

Top Keywords

bacterial translocase
8
streptomyces sank
8
sank 60404
8
translocase
5
a-94964
4
a-94964 novel
4
novel inhibitor
4
inhibitor bacterial
4
translocase produced
4
produced streptomyces
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!